MENGENAI EPISOD INI
Sep 7, 2026 – Boston College’s Dr. Thomas Seyfried tells Financial Sense Newshour’s Jim Puplava why he believes cancer is a mitochondrial metabolic disease—not primarily a genetic one. He explains why conventional treatments may miss the real driver...
Bahasa Inggeris
Amerika Syarikat
TRANSKRIP 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CARI EPISOD LEPAS
Cari episod lepas bagi Financial Sense Newshour.
EPISOD LAIN DALAM PODCAST INI
Oct 15, 2026 – The market keeps hitting records even as breadth collapses, yields however around 5%, and a $10 trillion Treasury refinancing wall approaches. Financial Sense Newshour's Jim Puplava sits down with Samantha LaDuc...
Oct 16, 2026 – Financial Sense CIO Chris Puplava discusses the scale and risks of the current AI investment boom, noting it surpasses previous U.S. infrastructure cycles in spending, but much of the benefit flows overseas. He highlights record...
Oct 16, 2026 – In this week's market wrap-up, Ryan Puplava discusses AI’s latest challenge with financing: Surging demand for AI is straining data center capacity, power, and especially companies’ ability to raise affordable capital...
Oct 14, 2026 – Peter Boockvar, author of The Boock Report, joins Financial Sense to break down the latest turbulence in memory chip stocks amid rising Chinese competition and AI-fueled market concentration. Boockvar highlights the dominance...
Oct 15, 2026 – Izabella Kaminska, founder of The Blind Spot, discusses the current sell-off, the big news regarding a potential slowdown in AI and tech capital expenditures, and liquidity flowing back to Treasuries. She highlights mounting...
Penafian: Podcast dan karya seni yang dibenamkan pada halaman ini adalah daripada Financial Sense, yang merupakan hak milik pemiliknya dan tidak bergabung dengan atau disokong oleh Listen Notes, Inc.
SUNTING
Terima kasih kerana membantu memastikan pangkalan data podcast dalam keadaan terkini.
